Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Diovan Data Manipulation Case Closed, Ruling Due Out in March
December 16, 2016
- Shinjiro Sato Tapped as Next President of Terumo
December 16, 2016
- Aspen Japan, Kissei Sign Copromotion Pact on Imuran
December 16, 2016
- Fujifilm to Acquire Takeda’s Reagent Unit for 155 Billion Yen
December 16, 2016
- Nippon Kayaku Introduces “MSLs” to Strengthen Detailing for Oncology Generics, Biosimilars, and Products in Development
December 16, 2016
- Interview: GSK’s New Evaluation System for Sales Reps Helps Deliver Science-Based Message
December 15, 2016
- FunPep, Shionogi Enter Joint Research Agreement for Vaccine Adjuvants
December 15, 2016
- Daiichi Sankyo Aims to File Antibody Drug Conjugate DS-8201 in 2020 for HER2-Positive Breast Cancer, Stomach Cancer
December 15, 2016
- Parkinson’s Med Nouriast Fails in PIII Study in US, Europe: Kyowa Kirin
December 14, 2016
- Daiichi Sankyo Links Arms with DarwinHealth on Cancer R&D
December 14, 2016
- Entyvio Delivers Higher Response Rates as 1st Line Biologic
December 13, 2016
- Astellas Europe to Transfer Rights for Pain Med Qutenza to Grünenthal
December 13, 2016
- Eisai’s BACE Inhibitor Cuts Beta Amyloid by 70% at 50 mg Daily
December 13, 2016
- Biogen Japan Seeks Japan Approval for Nusinersen
December 13, 2016
- Aspen Japan Starting on Right Foot on AG Biz: GSK Japan President
December 13, 2016
- Development of Novel Myeloid Leukemia Drug Gilteritinib Makes Progress: Astellas
December 12, 2016
- Mitsubishi Tanabe Wants to Make a Challenge in Experienced Field, President Says on Licensed Cell Therapy
December 9, 2016
- Nippon Kayaku Wins Reversal in Elplat Patent Suit
December 9, 2016
- Keytruda Launch Planned in Early Next Year: MSD Japan Chief
December 9, 2016
- Pfizer’s “Established” Pharma Business Expands to “Essential Health” to Include New Drugs, Copromoted Products
December 9, 2016
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…